Cargando…

Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China

The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhongjun, Qu, Tingting, Qi, Huiyang, Zhao, Shuchao, Shi, Hailei, Bai, Wenye, Yu, Yang, Wu, Xiao, Zhao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760017/
https://www.ncbi.nlm.nih.gov/pubmed/36540800
http://dx.doi.org/10.7717/peerj.14569
_version_ 1784852364054757376
author Wang, Zhongjun
Qu, Tingting
Qi, Huiyang
Zhao, Shuchao
Shi, Hailei
Bai, Wenye
Yu, Yang
Wu, Xiao
Zhao, Peng
author_facet Wang, Zhongjun
Qu, Tingting
Qi, Huiyang
Zhao, Shuchao
Shi, Hailei
Bai, Wenye
Yu, Yang
Wu, Xiao
Zhao, Peng
author_sort Wang, Zhongjun
collection PubMed
description The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed with a GT and 460 age-matched healthy controls (HCs) to estimate the infection process of T. gondii and understand the risk factors of T. gondii infection in patients with a GT. Levels of anti-T. gondii IgG and IgM were measured by enzyme-linked immunoassays every 12 months. After a median follow-up time of 4.3 years (range 4 to 5 years), 55/460 (11.96%) patients with a GT and 15/460 (3.26%) HCs were seroprevalence for T. gondii antibodies, respectively (P = 0.001). IgG antibodies against T. gondii were found in 54 GT patients (11.74%) and 15 HCs (3.26%), respectively (P = 0.001). The seroprevalence of T. gondii IgM antibodies was similar in patients with a GT and with HCs (2.83% vs 1.3%, P = 0.105). Multivariate stepwise logistic regression analysis revealed contact with cats (OR, 6.67; 95% CI [2.89–10.75]; P = 0.001), exposure to soil (OR, 2.16; 95% CI [1.14–4.10]; P = 0.019), being a farm-worker (OR, 4.17; 95% CI [1.20–11.49]; P = 0.006) and history of chemotherapy (OR, 3.16; 95% CI [1.56–6.45]; P = 0.001) to be independent risk factors for T. gondii infection. Women with an ovarian cancer or endometrial cancer had higher T. gondii seroprevalence than that of HCs. Moreover, T. gondii infection in patients with a GT mostly acquired within two years of diagnosis, but the infection in healthy controls had no obvious time characteristics. Here, we demonstrated that T. gondii infection is significantly higher in patients with a GT (especially in women with an ovarian tumor) compared to HCs. Thus, infection with this parasite should be avoided in patients with a GT, and the causal relationship between T. gondii and GTs should be studied in detail.
format Online
Article
Text
id pubmed-9760017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-97600172022-12-19 Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China Wang, Zhongjun Qu, Tingting Qi, Huiyang Zhao, Shuchao Shi, Hailei Bai, Wenye Yu, Yang Wu, Xiao Zhao, Peng PeerJ Parasitology The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed with a GT and 460 age-matched healthy controls (HCs) to estimate the infection process of T. gondii and understand the risk factors of T. gondii infection in patients with a GT. Levels of anti-T. gondii IgG and IgM were measured by enzyme-linked immunoassays every 12 months. After a median follow-up time of 4.3 years (range 4 to 5 years), 55/460 (11.96%) patients with a GT and 15/460 (3.26%) HCs were seroprevalence for T. gondii antibodies, respectively (P = 0.001). IgG antibodies against T. gondii were found in 54 GT patients (11.74%) and 15 HCs (3.26%), respectively (P = 0.001). The seroprevalence of T. gondii IgM antibodies was similar in patients with a GT and with HCs (2.83% vs 1.3%, P = 0.105). Multivariate stepwise logistic regression analysis revealed contact with cats (OR, 6.67; 95% CI [2.89–10.75]; P = 0.001), exposure to soil (OR, 2.16; 95% CI [1.14–4.10]; P = 0.019), being a farm-worker (OR, 4.17; 95% CI [1.20–11.49]; P = 0.006) and history of chemotherapy (OR, 3.16; 95% CI [1.56–6.45]; P = 0.001) to be independent risk factors for T. gondii infection. Women with an ovarian cancer or endometrial cancer had higher T. gondii seroprevalence than that of HCs. Moreover, T. gondii infection in patients with a GT mostly acquired within two years of diagnosis, but the infection in healthy controls had no obvious time characteristics. Here, we demonstrated that T. gondii infection is significantly higher in patients with a GT (especially in women with an ovarian tumor) compared to HCs. Thus, infection with this parasite should be avoided in patients with a GT, and the causal relationship between T. gondii and GTs should be studied in detail. PeerJ Inc. 2022-12-15 /pmc/articles/PMC9760017/ /pubmed/36540800 http://dx.doi.org/10.7717/peerj.14569 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Parasitology
Wang, Zhongjun
Qu, Tingting
Qi, Huiyang
Zhao, Shuchao
Shi, Hailei
Bai, Wenye
Yu, Yang
Wu, Xiao
Zhao, Peng
Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
title Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
title_full Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
title_fullStr Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
title_full_unstemmed Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
title_short Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
title_sort seroprevalence of toxoplasma gondii infection in women with a gynecological tumor living in eastern china
topic Parasitology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760017/
https://www.ncbi.nlm.nih.gov/pubmed/36540800
http://dx.doi.org/10.7717/peerj.14569
work_keys_str_mv AT wangzhongjun seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT qutingting seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT qihuiyang seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT zhaoshuchao seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT shihailei seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT baiwenye seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT yuyang seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT wuxiao seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina
AT zhaopeng seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina